News for Danske Bank A/S (DSN.F)

Denmark stocks lower at close of trade; OMX Copenhagen 20 down 1.24%

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the...

(Bloomberg) -- The European Central Bank’s pledges to fight back against unwarranted increases in bond yields are falling on deaf ears among investors.A selloff in bonds, which pushes up yields, was stemmed only temporarily on Thursday when ECB chief economist Philip Lane said officials will use the flexibility of their emergency bond-buying program to prevent any undue tightening in financial conditions. His colleague Isabel Schnabel gave a similar message earlier in the day.Yet Germany’s 10-year bond yield climbed to the highest level since March, its French equivalent rose above zero for the first time since June, and Italian yields climbed to the highest since November. Greek 10-year yields have doubled from a record low set in December.Bond yields are on the rise globally, in part due to spillovers from the U.S. economic recovery and the nation’s planned $1.9 trillion fiscal stimulus program. That’s testing central banks elsewhere, concerned that their own recoveries aren’t yet advanced enough to cope with higher borrowing costs.What Bloomberg Economics Says...“The reason for the rise in bond yields is benign. Global GDP prospects, driven by the U.S. outlook, have improved ... Having said that, the euro area is somewhat behind the world’s largest economy in terms of its recovery, and the ECB will therefore need to closely monitor financial markets.”-David Powell. To read his report, click hereLane said that while ECB officials “always welcome the rest of the world growing more quickly,” they recognize the risk to the euro zone.He echoed ECB President Christine Lagarde’s remark this week that the ECB is “closely monitoring” bond yields, and signaled that the pace of the 1.85 trillion-euro ($2.26 trillion) pandemic bond-buying program can be stepped up if needed.“Lane didn’t tell us anything new,” said Rohan Khanna, rates strategist at UBS Group AG. “ECB bond-buying can’t prevent yields from rising if the macro outlook is one of roaring growth.”The euro area is in a particularly uncomfortable spot, with an economic contraction likely this quarter because of a slow vaccine rollout and extended virus restrictions. Its own relatively small and drawn-out fiscal stimulus means output will only return to pre-pandemic levels around the middle of 2022, a full year behind the U.S.Read more: Europe’s Recovery Choices Will Leave It a Year Behind the U.S.The ECB has pledged to keep financing conditions “favorable” through the crisis, a point that Lane reiterated. He said that term applies to “the whole transmission chain of our monetary policy -- from risk-free rates to government borrowing costs to capital markets to the terms and pricing of bank lending to firms and households.”“We don’t find any significant new messages in his remarks so far that it is enough to stop the current euro-area government bond momentum,” said Piet Christiansen, chief strategist at Danske Bank A/S.Lane also said monetary policy must do more than merely counter the shock of the coronavirus, meaning the ECB will provide support “for an extended period, even after the disinflationary pressures caused by the pandemic have been sufficiently offset.”(Updates with analysis by Bloomberg Economics after fourth paragraph)For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2021 Bloomberg L.P.

/PRNewswire/ -- Nanoform Finland Plc, an innovative nanoparticle medicine enabling company, today announced further positive interim results from its ongoing...

(Bloomberg) -- Estonia will no longer lobby the U.S. to get a share of any potential fine imposed on Danske Bank A/S in connection with an ongoing money laundering investigation.

Denmark stocks higher at close of trade; OMX Copenhagen 20 up 0.78%

HELSINKI, Feb. 12, 2021 /PRNewswire/ -- Nanoform Finland Plc ('Nanoform'), an innovative nanoparticle medicine enabling company, will publish its ...

HELSINKI, Feb. 12, 2021 /PRNewswire/ -- Nanoform Finland Plc ('Nanoform'), an innovative nanoparticle medicine enabling company, will publish its ...

Christian Sagild ELECTED BY THE GENERAL MEETING Born on ... | February 11, 2021

The dollar dropped to two-week lows on Wednesday in choppy trading, led by losses against sterling and the euro, weighed down by U.S. data showing tepid inflation and a slippage in Treasury... | February 10, 2021

HELSINKI, Feb. 9, 2021 /PRNewswire/ -- Nanoform Finland Plc, an innovative nanoparticle medicine enabling company, and Herantis Pharma Plc, an inn...

HELSINKI, Feb. 9, 2021 /PRNewswire/ -- Nanoform Finland Plc, an innovative nanoparticle medicine enabling company, and Herantis Pharma Plc, an inn...

HELSINKI, Feb. 9, 2021 /PRNewswire/ -- Nanoform Finland Plc, an innovative nanoparticle medicine enabling company, and Herantis Pharma Plc, an innovative ...

Denmark stocks higher at close of trade; OMX Copenhagen 20 up 0.17%

PPG PPG and Tikkurila (NASDAQ OMX:TIK1V) today announced the companies have entered into an amendment to the previously announced definitive combination

Company announcement – No. 4 / 2021 NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN OR SOUTH AFRICA,... | February 1, 2021

Company announcement – No. 4 / 2021 NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN OR SOUTH AFRICA, EXCEPT AS PERMITTED BY APPLICABLE LAW. THIS ANNOUNCEMENT IS NOT AN OFFER OF SECURITIES FOR SALE IN THE UNITED STATES AND THE SECURITIES REFERRED TO HEREIN MAY NOT BE OFFERED OR SOLD IN THE UNITED STATES ABSENT REGISTRATION EXCEPT PURSUANT TO AN EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE U.S. SECURITIES ACT; ANY PUBLIC OFFERING OF SUCH SECURITIES TO BE MADE IN THE UNITED STATES WILL BE MADE BY MEANS OF A PROSPECTUS THAT MAY BE OBTAINED FROM THE ISSUER, WHICH WOULD CONTAIN DETAILED INFORMATION ABOUT THE COMPANY AND MANAGEMENT, AS WELL AS FINANCIAL STATEMENTS. Zealand has today completed and registered a capital increase of 3,600,841 new shares Copenhagen, 1 February 2021 – Further to the company announcements no. 2 and 3/2021, Zealand Pharma A/S (

Denmark stocks higher at close of trade; OMX Copenhagen 20 up 0.42%

HELSINKI, Jan. 22, 2021 /PRNewswire/ -- Nanoform Finland Plc ('Nanoform'), an innovative nanoparticle medicine enabling company, today announced p...